Brought to you by 
Invuity raises $25mm in Series D round
16 Aug 2012
Executive Summary
Invuity Inc. (surgical visualization technology) brought in $25mm via its Series D financing round led by Valence Advantage Life Sciences Fund II (managed by newly formed Valence Life Sciences LLC, formerly Caxton Advantage Venture Partners), with participation from return backers Kleiner Perkins Caufield & Byers, InterWest Partners, and Wexford Capital. A representative from Valence Advantage will join the Invuity board.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Invuity raises $25mm in Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice